Phil is closing his PhD in Molecular Biophysics at UCL and Imperial College London. He is an expert in deciphering how DNA interacts with small molecule therapeutics and proteins, partnering with AstraZeneca and several other research groups. He is a specialist in AI and microscopy R&D across London and California.
Company:
PentaBind
AI-powered aptamer discovery, unlocking the next generation of continuous monitoring biosensors and therapeutics.
View Company